Over the last 12 months, four InMed Pharmaceuticals Inc. executives and directors bought into shares at market prices, about $1.3 million in total, and none of them sold.
Schneeberger Daniel (10% Owner) made the biggest buy, worth around $312,000.
Quarter by quarter: 2 quarters in a row of net buying by insiders. Insiders bought in 2 of the last 7 full quarters. Big money check: 20 institutions held INM as of Q2 2026, and more funds bought than sold.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy | 2,256 | $1.33 | $3K | SEC |
| Oct 8, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy | 5,601 | $1.33 | $7K | SEC |
| Oct 8, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy | 3,046 | $1.33 | $4K | SEC |
| Oct 5, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy | 8,307 | $1.33 | $11K | SEC |
| Oct 5, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy | 18,182 | $1.33 | $24K | SEC |
| Oct 5, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy | 16,431 | $1.33 | $22K | SEC |
| Sep 16, 2026 | Schneeberger Daniel | 10% Owner | Buy | 28,505 | $1.29 | $37K | SEC |
| Sep 16, 2026 | Schneeberger Daniel | 10% Owner | Buy | 8,340 | $1.29 | $11K | SEC |
| Sep 16, 2026 | Schneeberger Daniel | 10% Owner | Buy | 54,256 | $1.30 | $71K | SEC |
| Jul 17, 2026 | ADAR1 Capital Management, LLC | 10% Owner | Buy | 1,000 | $1.56 | $2K | SEC |
| Jul 16, 2026 | Vivo Opportunity Cayman Fund, L.P. | 10% Owner | Buy | 493 | $1.55 | $764 | SEC |
| Jul 16, 2026 | Vivo Opportunity Cayman Fund, L.P. | 10% Owner | Buy | 4,882 | $1.55 | $8K | SEC |
| Jul 16, 2026 | Vivo Opportunity Cayman Fund, L.P. | 10% Owner | Buy | 2 | $1.55 | $3 | SEC |
| Jul 16, 2026 | Vivo Opportunity Cayman Fund, L.P. | 10% Owner | Buy | 19 | $1.55 | $29 | SEC |
| Jul 16, 2026 | Vivo Opportunity Cayman Fund, L.P. | 10% Owner | Buy | 13,761 | $1.55 | $21K | SEC |
In the last 12 months InMed Pharmaceuticals Inc. insiders made open-market purchases worth about $1.3 million and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in INM was filed on 2026-10-08.
20 investment managers reported holding INM in SEC Form 13F filings for Q2 2026.
No congressional trades in INM were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).